These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5350917)

  • 1. [Effect of cycloserine on the human body].
    Rózewska M; Gajewska E; Graczyk J
    Gruzlica; 1969 Jun; 37(6):523-8. PubMed ID: 5350917
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of chemotherapy in patients with pulmonary tuberculosis in Uzbekistan].
    Alimov ShA; Abdurashitova MV; Udrit OO; Azarnykh MA; Bruk AZ
    Probl Tuberk; 1969; 47(3):1-5. PubMed ID: 4242896
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin in patients with most severe tuberculosis].
    Reimers D
    Prax Pneumol; 1969 May; 23(5):322-30. PubMed ID: 5801953
    [No Abstract]   [Full Text] [Related]  

  • 5. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
    Rabukhin AE; Alekseeva VM; Ivanova ES; Kubyshkina VF; Kliuchareva EA
    Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 8. [Terisidon in chemotherapy of pulmonary tuberculosis].
    Kolosovskaia VP; Korotaev GA
    Probl Tuberk; 1974; (12):15-8. PubMed ID: 4445129
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP; Agarwala MC; Singh SK
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of clinical trials of a new antitubercular agent, terizidone (Terivalidine)].
    Zrilić V; Mijatović M; Mirković S; Muzikravić T
    Plucne Bolesti Tuberk; 1972; 24(2):89-98. PubMed ID: 4565191
    [No Abstract]   [Full Text] [Related]  

  • 12. Results after retreatment of advanced pulmonary tuberculosis with rifampin and other drugs.
    Pines A
    Am Rev Respir Dis; 1971 Jul; 104(1):126-7. PubMed ID: 4104090
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR; Lind A; Rist N
    Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884
    [No Abstract]   [Full Text] [Related]  

  • 14. On cycloserine in the treatment of pulmonary tuberculosis and its use for postoperative protection.
    Rivas Salazar JL
    Scand J Respir Dis Suppl; 1970; 71():314-24. PubMed ID: 5272002
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H; Takahashi R; Nakai T; Torii R; Yo I
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract]   [Full Text] [Related]  

  • 16. Cycloserine and clinical phthisiology.
    Zapatero J; Garcia Moreno F; Torres G; Santamaria A; Ventura A
    Scand J Respir Dis Suppl; 1970; 71():252-5. PubMed ID: 5271996
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of the second chemotherapy trial of the IUAT. Bacteriological part.
    Lind A; Rist N
    Bull Int Union Tuberc; 1968 Dec; 41():178. PubMed ID: 5710246
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M
    Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
    [No Abstract]   [Full Text] [Related]  

  • 20. Cycloserine induced psychosis with hepatic dysfunction.
    Tandon VR; Rani N; Roshi ; Gupta R; Arora M; Khajuria V; Mahajan V
    Indian J Pharmacol; 2015; 47(2):230-1. PubMed ID: 25878391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.